Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment optimization and genomic outcomes in refractory severe aplastic anemia treated with eltrombopag
Thomas Winkler, Xing Fan, James Cooper, et al.
Blood (2019) Vol. 133, Iss. 24, pp. 2575-2585
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline
Austin Kulasekararaj, Jamie Cavenagh, Inderjeet Dokal, et al.
British Journal of Haematology (2024) Vol. 204, Iss. 3, pp. 784-804
Open Access | Times Cited: 35
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
Amy E. DeZern, Marianna Zahurak, Heather J. Symons, et al.
Blood Advances (2020) Vol. 4, Iss. 8, pp. 1770-1779
Open Access | Times Cited: 122
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria
Lova Sun, Daria V. Babushok
Blood (2020) Vol. 136, Iss. 1, pp. 36-49
Open Access | Times Cited: 93
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study
Bhavisha A. Patel, Emma M. Groarke, Jennifer Lotter, et al.
Blood (2021) Vol. 139, Iss. 1, pp. 34-43
Open Access | Times Cited: 81
Acquired severe aplastic anaemia: how medical therapy evolved in the 20th and 21st centuries
Phillip Scheinberg
British Journal of Haematology (2021) Vol. 194, Iss. 6, pp. 954-969
Open Access | Times Cited: 57
Toward a pathophysiology inspired treatment of VEXAS syndrome
Maël Heiblig, Bhavisha A. Patel, Emma M. Groarke, et al.
Seminars in Hematology (2021) Vol. 58, Iss. 4, pp. 239-246
Open Access | Times Cited: 55
Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia
Emma M. Groarke, Bhavisha A. Patel, Fernanda Gutierrez‐Rodrigues, et al.
British Journal of Haematology (2021) Vol. 192, Iss. 3, pp. 605-614
Open Access | Times Cited: 44
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia
Emma M. Groarke, Bhavisha A. Patel, Ruba Shalhoub, et al.
Leukemia (2022) Vol. 36, Iss. 9, pp. 2328-2337
Open Access | Times Cited: 34
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome: From Megakaryopoiesis to Immunomodulation
Bruno Fattizzo, Giorgia Levati, Ramona Cassin, et al.
Drugs (2019) Vol. 79, Iss. 12, pp. 1305-1319
Closed Access | Times Cited: 53
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome
Alana Vicente, Bhavisha A. Patel, Fernanda Gutierrez‐Rodrigues, et al.
Haematologica (2020) Vol. 105, Iss. 12, pp. 2785-2794
Open Access | Times Cited: 49
Current evidence and the emerging role of eltrombopag in severe aplastic anemia
Beatrice Drexler, Jakob Passweg
Therapeutic Advances in Hematology (2021) Vol. 12, pp. 204062072199812-204062072199812
Open Access | Times Cited: 33
A multicenter phase II study on the efficacy and safety of hetrombopag in patients with severe aplastic anemia refractory to immunosuppressive therapy
Guangxin Peng, Guangsheng He, Hong Chang, et al.
Therapeutic Advances in Hematology (2022) Vol. 13
Open Access | Times Cited: 23
Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias
Xing Fan, Ronan Desmond, Thomas Winkler, et al.
Blood Advances (2020) Vol. 4, Iss. 8, pp. 1700-1710
Open Access | Times Cited: 39
Idiopathic aplastic anemia vs hypocellular myelodysplastic syndrome
Jibran Durrani, Jaroslaw P. Maciejewski
Hematology (2019) Vol. 2019, Iss. 1, pp. 97-104
Open Access | Times Cited: 37
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia
Yihong Guan, Metis Hasipek, Dongxu Jiang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 22
Progress in medical therapy in aplastic anemia: why it took so long?
Phillip Scheinberg
International Journal of Hematology (2024) Vol. 119, Iss. 3, pp. 248-254
Open Access | Times Cited: 4
Mechanisms and therapeutic prospects of thrombopoietin receptor agonists
James B. Bussel, Austin Kulasekararaj, Nichola Cooper, et al.
Seminars in Hematology (2019) Vol. 56, Iss. 4, pp. 262-278
Closed Access | Times Cited: 32
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open‐label study
Jun Ho Jang, Yoshiaki Tomiyama, Kôji Miyazaki, et al.
British Journal of Haematology (2020) Vol. 192, Iss. 1, pp. 190-199
Open Access | Times Cited: 30
Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia
Aura Enache, Shannon A. Carty, Daria V. Babushok
British Journal of Haematology (2025)
Open Access
Iron deficiency anemia following long-term eltrombopag treatment for aplastic anemia: a single-institution experience
Ryusuke Yamamoto, Nobuhiro Hiramoto, Yuya Nagai, et al.
International Journal of Hematology (2025)
Closed Access
Immunosuppressive therapy in severe aplastic anemia
Bhavisha A. Patel, Danielle M. Townsley, Phillip Scheinberg
Seminars in Hematology (2022) Vol. 59, Iss. 1, pp. 21-29
Closed Access | Times Cited: 15
Avatrombopag for the salvage treatment of platelet transfusion refractoriness
Yue-Hong Qin, Yu Wang, Yujiao Zhang, et al.
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 3
Management of aplastic anemia after failure of frontline immunosuppression
Filomena Pierri, Carlo Dufour
Expert Review of Hematology (2019) Vol. 12, Iss. 10, pp. 809-819
Closed Access | Times Cited: 24
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study
Meixin Fang, Hua Song, Jingying Zhang, et al.
Pediatric Hematology and Oncology (2021) Vol. 38, Iss. 7, pp. 633-646
Closed Access | Times Cited: 20
Avatrombopag for the treatment of thrombocytopenia post hematopoietic stem-cell transplantation
Meng Zhou, Jiaqian Qi, Chengyuan Gu, et al.
Therapeutic Advances in Hematology (2022) Vol. 13
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top